Profile: Wyeth Limited provides new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, Alzheimer's disease, and schizophrenia. We provide pharmaceuticals in the areas of women's health care, neuroscience, musculoskeletal disorders, hemophilia and oncology. Our efforts in oncology include chemotherapy agents for acute myeloid leukemia, renal cell cancer, and a platelet growth promoter to help patients after chemotherapy. Our product neumega® is ideal for the prevention of severe thrombocytopenia & in the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. We offer ketaset® (ketamine hydrochloride) which is a rapid-acting anesthetic for diagnostic or minor surgeries.